At follow up (6th and 12th month), MS patients vs. no MS patients still had higher levels of failing heart stress biomarkers (BNP at 6th month 182.95 ± 37.51 vs. 107.14 ± 33.25 mmol/l, p-value 0.0035; BNP at 12th month 175.41 ± 34.21 vs. 103.22 ± 31.25 mmol/l, p-value 0.004; ST2 protein at 6th month 114.12 ± 5.1 vs. 57 ± 7.32 ng/ml, p-value 0.031; ST2 at 12th month 111.38 ± 5.3 vs. 53 ± 7.12 ng/ml, p-value 0.004). Here, NPPB is linked to myeloid sarcoma.